AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $88.31
- 52-wk low
- $35.22
- Prev close
- $63.72
- Mkt cap
- $10.73B
- Fwd P/E
- 117.7x
- Beta
- 0.38
Smart money
Earnings
Earnings came in 8.0% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.9M | $17.8M | $19.4M | $31.9M |
| Cost of what it sold | $2.7M | $2.9M | $2.4M | $2.7M |
| Gross profit | -$743.0K | $14.9M | $17.0M | $29.2M |
| What it spent | ||||
| Research and development | $99.2M | $101.5M | $95.5M | $97.8M |
| Sales and admin | $69.5M | $91.7M | $104.9M | $104.4M |
| Other operating costs | -$2.7M | — | — | $2.9M |
| Total operating expenses | $166.0M | $193.3M | $200.6M | $205.1M |
| What was left | ||||
| Operating profit | -$166.8M | -$178.4M | -$183.6M | -$175.9M |
| Interest on debt | $26.3M | $30.3M | $33.3M | $34.8M |
| Profit before tax | -$306.2M | -$183.0M | -$206.0M | -$198.8M |
| Net profit | -$306.2M | -$183.0M | -$206.0M | -$198.8M |
| EBITDA | -$277.2M | -$180.4M | -$169.3M | -$191.8M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
33 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Cytokinetics (NASDAQ:CYTK) Raised to Hold at Wall Street Zen
Leans bullishAug 16Will MYQORZO Traction Amid Weaker Q2 2026 Results Change Cytokinetics' (CYTK) Narrative
Leans bullishAug 15Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
NeutralAug 14
